Clinical predictors of 3-month isoniazid rifapentine (3HP)-related adverse drug reactions (ADR) during tuberculosis preventive therapy (PAnDoRA-3HP study): an observational study p... by Turyahabwe Stavia, Barbara Castelnuovo, Christine Sekaggya-Wiltshire, Kelly E Dooley, Grace Banturaki, Irene Mbabazi, Ruth Mirembe Nabisere, Lucy Alinaitwe, Brian Otaalo, Florence Aber, Juliet Nampala, Rogers Owori, Josephine Bayigga, Jonathan Mayito, Eva Agnes Odongpiny Laker, Moorine Penninah Sekadde, Jotam Pasipanodya, Stella Zawedde‐Muyanja

Get full text

The long-term impact of the COVID-19 pandemic on tuberculosis care and infection control measures in anti-retroviral therapy (ART) clinics in low- and middle-income countries: a mu... by Marcel Yotebieng, Lukas Fenner, Haruka Uemura, Jacqueline Huwa, Ellen Brazier, Marie Ballif, Oliver Ezechi, Anchalee Avihingsanon, Denna Michael, Jonathan Euvrard, Guy Muula, Nagalingeswaran Kumarasamy, Lameck Diero, Brian Otaalo, Eric Komena, Nicolas Banholzer, Lisa Perrig, Dominique Mahambu Nsonde, Sarah Obatsa, Patricia Lelo, Patrice Gouéssé, Idiovino Rafael, Richard Ramdé, I Ketut Agus Somia

Get full text